+Search query
-Structure paper
Title | Discovery of an Orally Bioavailable, Brain-Penetrating, in Vivo Active Phosphodiesterase 2A Inhibitor Lead Series for the Treatment of Cognitive Disorders. |
---|---|
Journal, issue, pages | J. Med. Chem., Vol. 60, Page 7658-7676, Year 2017 |
Publish date | May 8, 2017 (structure data deposition date) |
![]() | Mikami, S. / Sasaki, S. / Asano, Y. / Ujikawa, O. / Fukumoto, S. / Nakashima, K. / Oki, H. / Kamiguchi, N. / Imada, H. / Iwashita, H. / Taniguchi, T. |
![]() | ![]() ![]() |
Methods | X-ray diffraction |
Resolution | 2.16 Å |
Structure data | ![]() PDB-5xkm: |
Chemicals | ![]() ChemComp-MG: ![]() ChemComp-ZN: ![]() ChemComp-87R: ![]() ChemComp-HOH: |
Source |
|
![]() | HYDROLASE / Hydrolase Inhibitor / PDE2A |